ArticleTranslational gastroenterology and hepatology2026
Postoperative course of C-reactive protein level after liver surgery-when to worry?
Article in Translational gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: C-reactive protein (CRP) level is an established marker to detect inflammation and infectious complications after surgical procedures, but its use after liver surgery has not been well investigated. This study aimed to elucidate the role of CRP level after elective liver resection and to determine baseline values for a normal postoperative course, as well as the role of CRP level as a predictor of postoperative complications. Methods: All liver resections performed between January 2008 and December 2023 were identified. Patients' characteristics, intraoperative data and postoperative outcomes were analyzed. Postoperative surgical complications within 90 days were graded using the Clavien-Dindo classification system. The postoperative CRP values from postoperative day (POD) 1 to 10 were included. Results: In total, 3,177 liver resections were identified during the study period, of which 85.1% (2,705) were performed for malignant liver disease. In 1,647 (51.8%) cases, there were no postoperative complications. The median CRP level in cases without complication (baseline) was 55 mg/L on POD 1, 130 mg/L on POD 2, 128 mg/L on POD 3, 101 mg/L on POD 4, 80 mg/L on POD 5, 70 mg/L on POD 7 and 120 mg/L on POD 10. The percentage of cases who suffered complications (highest grade) was 7.3% (n=232) with grade I, 14.5% (n=462) grade II, 14.5% (n=461) grade IIIa, 4.2% (n=132) grade IIIb, 3.7% (n=117) grade IVa, 0.4% (14) grade IVb, and 3.5% (n=112) with grade V complications. Infectious complications occurred in 28.9% (n=919) and severe infectious complications (≥ grade IIIa) in 20.4% (n=648) of the cases. The median CRP values in cases with infectious complication were significantly higher on POD 1 (59 mg/L; P=0.01), POD 2 (143 mg/L; P<0.001), POD 3 (164 mg/L; P<0.001), POD 4 (149 mg/L; P<0.001), POD 5 (134 mg/L; P<0.001) and POD 7 (114 mg/L; P=0.043). In multivariate analysis, only elevated CRP values on POD 5 (P=0.003) were predictors for infectious complications. The AUC for POD 5 was the highest at 0.72 and presented the highest predictive accuracy. The optimal cut-off value for CRP level POD 5 was 93 mg/L. The positive and negative predictive values (PPV/NPV) for the cut-off value POD 5 were 79.6% and 87.6%, respectively. Conclusions: Postoperative elevated CRP level on POD 5 is a valuable predictive tool for early detection of infectious complications after liver surgery and can help in decision making for further diagnostic measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.